Emilia Andersson

3.0k total citations
26 papers, 519 citations indexed

About

Emilia Andersson is a scholar working on Oncology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Emilia Andersson has authored 26 papers receiving a total of 519 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 14 papers in Immunology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Emilia Andersson's work include Immune Cell Function and Interaction (12 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Immunotherapy and Immune Responses (7 papers). Emilia Andersson is often cited by papers focused on Immune Cell Function and Interaction (12 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Immunotherapy and Immune Responses (7 papers). Emilia Andersson collaborates with scholars based in Sweden, Germany and United States. Emilia Andersson's co-authors include Giuseppe Masucci, Rolf Kiessling, Lisa Villabona, Barbara Seliger, Tina Dalianis, Andreas Lundqvist, Anders Näsman, Torbjörn Ramqvist, Isabel Poschke and Eva Munck‐Wikland and has published in prestigious journals such as PLoS ONE, Annals of Oncology and International Journal of Cancer.

In The Last Decade

Emilia Andersson

26 papers receiving 513 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emilia Andersson Sweden 12 284 278 125 88 80 26 519
Simona Partlová Czechia 7 294 1.0× 302 1.1× 106 0.8× 52 0.6× 65 0.8× 12 497
Benjamin Kansy Germany 10 329 1.2× 400 1.4× 139 1.1× 75 0.9× 51 0.6× 26 629
Ilina Ehsan Netherlands 10 427 1.5× 434 1.6× 116 0.9× 66 0.8× 64 0.8× 10 646
Vanessa J. van Ham Netherlands 7 476 1.7× 429 1.5× 123 1.0× 52 0.6× 59 0.7× 8 651
Jean-Pascal H. Machiels United States 5 368 1.3× 435 1.6× 141 1.1× 30 0.3× 163 2.0× 7 702
Clément Barjon France 12 320 1.1× 203 0.7× 217 1.7× 134 1.5× 15 0.2× 17 529
Makiko Moriyama‐Kita Japan 12 62 0.2× 161 0.6× 172 1.4× 105 1.2× 61 0.8× 28 353
Samantha Leung United States 5 134 0.5× 251 0.9× 160 1.3× 54 0.6× 39 0.5× 6 412
Nathalie Merillon France 6 353 1.2× 369 1.3× 186 1.5× 82 0.9× 11 0.1× 8 594
Marya Chaney United States 11 223 0.8× 348 1.3× 104 0.8× 25 0.3× 17 0.2× 59 501

Countries citing papers authored by Emilia Andersson

Since Specialization
Citations

This map shows the geographic impact of Emilia Andersson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emilia Andersson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emilia Andersson more than expected).

Fields of papers citing papers by Emilia Andersson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emilia Andersson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emilia Andersson. The network helps show where Emilia Andersson may publish in the future.

Co-authorship network of co-authors of Emilia Andersson

This figure shows the co-authorship network connecting the top 25 collaborators of Emilia Andersson. A scholar is included among the top collaborators of Emilia Andersson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emilia Andersson. Emilia Andersson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kraxner, Anton, Wei‐Yi Cheng, Tai-Hsien Ou Yang, et al.. (2024). Investigating the complex interplay between fibroblast activation protein α-positive cancer associated fibroblasts and the tumor microenvironment in the context of cancer immunotherapy. Frontiers in Immunology. 15. 1352632–1352632. 8 indexed citations
2.
Dziadek, Sebastian, Anton Kraxner, Wei‐Yi Cheng, et al.. (2024). Comprehensive analysis of fibroblast activation protein expression across 23 tumor indications: insights for biomarker development in cancer immunotherapies. Frontiers in Immunology. 15. 1352615–1352615. 15 indexed citations
3.
Danielsbacka, Mirkka, et al.. (2022). Predictors of Social Media Use in Two Family Generations. Frontiers in Sociology. 6. 813765–813765. 4 indexed citations
4.
Dziadek, Sebastian, Anton Kraxner, Wei‐Yi Cheng, et al.. (2021). 86 Extensive FAP expression analysis in 23 tumor indications and potential application in defining the patient population in FAP-targeting cancer immunotherapies. Regular and Young Investigator Award Abstracts. A94–A94. 1 indexed citations
5.
Andersson, Emilia, Nils Nyhlin, & Michiel A. van Nieuwenhoven. (2021). The effectiveness of the colorectal cancer referral pathway – identification of colorectal cancer in a Swedish region. Scandinavian Journal of Gastroenterology. 56(5). 552–558. 4 indexed citations
6.
Schwen, Lars Ole, Emilia Andersson, Konstanty Korski, et al.. (2018). Data-Driven Discovery of Immune Contexture Biomarkers. Frontiers in Oncology. 8. 627–627. 20 indexed citations
7.
Melero, Ignacio, Neil H. Segal, Willeke Ros, et al.. (2017). Pharmacokinetics (PK) and pharmacodynamics (PD) of a novel carcinoembryonic antigen (CEA) T-cell bispecific antibody (CEA-CD3 TCB) for the treatment of CEA-positive solid tumors. Annals of Oncology. 28. v28–v28. 2 indexed citations
8.
Andersson, Emilia, Isabel Poschke, Lisa Villabona, et al.. (2015). Non-classical HLA-class I expression in serous ovarian carcinoma: Correlation with the HLA-genotype, tumor infiltrating immune cells and prognosis. OncoImmunology. 5(1). e1052213–e1052213. 55 indexed citations
9.
Koelzer, Viktor H., Heather Dawson, Emilia Andersson, et al.. (2015). Active immunosurveillance in the tumor microenvironment of colorectal cancer is associated with low frequency tumor budding and improved outcome. Translational research. 166(2). 207–217. 40 indexed citations
10.
Villabona, Lisa, D Rodríguez, Emilia Andersson, et al.. (2014). A novel approach for HLA-A typing in formalin-fixed paraffin-embedded-derived DNA. Modern Pathology. 27(9). 1296–1305. 4 indexed citations
11.
Poschke, Isabel, Tanja Lövgren, Lars Adamson, et al.. (2014). A phase I clinical trial combining dendritic cell vaccination with adoptive T cell transfer in patients with stage IV melanoma. Cancer Immunology Immunotherapy. 63(10). 1061–1071. 57 indexed citations
12.
Näsman, Anders, Emilia Andersson, Linda Marklund, et al.. (2013). HLA Class I and II Expression in Oropharyngeal Squamous Cell Carcinoma in Relation to Tumor HPV Status and Clinical Outcome. PLoS ONE. 8(10). e77025–e77025. 66 indexed citations
13.
Marchesi, Maddalena, Emilia Andersson, Lisa Villabona, et al.. (2013). HLA-dependent tumour development: a role for tumour associate macrophages?. Journal of Translational Medicine. 11(1). 247–247. 62 indexed citations
14.
Du, Juan, Anders Näsman, Emilia Andersson, et al.. (2012). Prevalence of Human Papillomavirus (HPV) in Oesophageal Squamous Cell Carcinoma in Relation to Anatomical Site of the Tumour. PLoS ONE. 7(10). e46538–e46538. 30 indexed citations
15.
Näsman, Anders, Emilia Andersson, Cecilia Nordfors, et al.. (2012). MHC class I expression in HPV positive and negative tonsillar squamous cell carcinoma in correlation to clinical outcome. International Journal of Cancer. 132(1). 72–81. 47 indexed citations
16.
Andersson, Emilia, Lisa Villabona, Kjell Bergfeldt, et al.. (2012). Correlation of HLA-A02* genotype and HLA class I antigen down-regulation with the prognosis of epithelial ovarian cancer. Cancer Immunology Immunotherapy. 61(8). 1243–1253. 30 indexed citations
17.
Masucci, Giuseppe, Emilia Andersson, Lisa Villabona, et al.. (2010). Survival of the fittest or best adapted: HLA-dependent tumor development. e9–e9. 1 indexed citations
18.
Masucci, Giuseppe, Emilia Andersson, Lisa Villabona, et al.. (2010). Survival of the fittest or best adapted: HLA-dependent tumor development. 1(1). 9–9. 2 indexed citations
19.
Helgadóttir, Hildur, Emilia Andersson, Lisa Villabona, et al.. (2009). The common Scandinavian human leucocyte antigen ancestral haplotype 62.1 as prognostic factor in patients with advanced malignant melanoma. Cancer Immunology Immunotherapy. 58(10). 1599–1608. 11 indexed citations
20.
Villabona, Lisa, Geert W. Haasnoot, Emilia Andersson, et al.. (2007). Analysis of HLA class I–II haplotype frequency and segregation in a cohort of patients with advanced stage ovarian cancer. Tissue Antigens. 70(3). 205–213. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simona Partlová Breakdown of academic impact, for papers by Benjamin Kansy Breakdown of academic impact, for papers by Ilina Ehsan Breakdown of academic impact, for papers by Vanessa J. van Ham Breakdown of academic impact, for papers by Jean-Pascal H. Machiels Breakdown of academic impact, for papers by Clément Barjon Breakdown of academic impact, for papers by Makiko Moriyama‐Kita Breakdown of academic impact, for papers by Samantha Leung Breakdown of academic impact, for papers by Nathalie Merillon Breakdown of academic impact, for papers by Marya Chaney
Rankless by CCL
2026